Don Giddens

Covanos, Inc. is an American medical technology company that has developed a technology platform combining advanced mathematical methods and computational fluid dynamics with clinical imaging to determine the functional significance of arterial blockages. The private company is based in Atlanta and was founded by Habib Samady. The company's first product, C-Heart, is a non-invasive, out-patient based, point-of-care, PC-based workstation solution that determines whether a patient with chest pain requires re-vascularization of a coronary artery blockage. Russell M. Medford has been the CEO of the company since 2014.

Covanos, Inc. is an American medical technology company that has developed a technology platform combining advanced mathematical methods and computational fluid dynamics with clinical imaging to determine the functional significance of arterial blockages. The private company is based in Atlanta and was founded by Habib Samady. The company's first product, C-Heart, is a non-invasive, out-patient based, point-of-care, PC-based workstation solution that determines whether a patient with chest pain requires re-vascularization of a coronary artery blockage. Russell M. Medford has been the CEO of the company since 2014.

Covanos, Inc. is an American medical technology company that has developed a technology platform combining advanced mathematical methods and computational fluid dynamics with clinical imaging to determine the functional significance of arterial blockages. The private company is based in Atlanta and was founded by Habib Samady. The company's first product, C-Heart, is a non-invasive, out-patient based, point-of-care, PC-based workstation solution that determines whether a patient with chest pain requires re-vascularization of a coronary artery blockage. Russell M. Medford has been the CEO of the company since 2014.

Covanos, Inc. is an American medical technology company that has developed a technology platform combining advanced mathematical methods and computational fluid dynamics with clinical imaging to determine the functional significance of arterial blockages. The private company is based in Atlanta and was founded by Habib Samady. The company's first product, C-Heart, is a non-invasive, out-patient based, point-of-care, PC-based workstation solution that determines whether a patient with chest pain requires re-vascularization of a coronary artery blockage. Russell M. Medford has been the CEO of the company since 2014.

Covanos, Inc. is an American medical technology company that has developed a technology platform combining advanced mathematical methods and computational fluid dynamics with clinical imaging to determine the functional significance of arterial blockages. The private company is based in Atlanta and was founded by Habib Samady. The company's first product, C-Heart, is a non-invasive, out-patient based, point-of-care, PC-based workstation solution that determines whether a patient with chest pain requires re-vascularization of a coronary artery blockage. Russell M. Medford has been the CEO of the company since 2014.